Literature DB >> 32206131

Role of 68Ga-DOTATATE PET/CT in a Case of SDHB-Related Pterygopalatine Fossa Paraganglioma Successfully Controlled with Octreotide.

Abhishek Jha1, Mayank Patel1, Eva Baker2, Melissa K Gonzales1, Alexander Ling2, Corina Millo3, Marianne Knue1, Ali Cahid Civelek4, Karel Pacak1.   

Abstract

We describe an unusual case of a 42-year-old female with an unresectable succinate dehydrogenase subunit B (SDHB)-related pterygopalatine fossa paraganglioma. She underwent somatostatin receptor imaging with 68Ga-DOTA(0)-Tyr(3)-octreotate (68Ga-DOTATATE) positron emission tomography/computed tomography (PET/CT), which showed uptake in the above mentioned tumor. Hence, the patient was started on octreotide, a cold somatostatin analog, and responded with tumor stabilization and improvement of clinical symptoms for 36 months since initiation of octreotide therapy. This case demonstrates the role of 68Ga-DOTATATE PET/CT in diagnostic localization and its subsequent role in treatment using cold somatostatin analog as a potential choice of therapy in the management of paraganglioma in an unusual location with limited therapeutic options. © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020.

Entities:  

Keywords:  177Lu-DOTATATE; 68Ga-DOTATATE PET/CT; Octreotide; PRRT; Paraganglioma; SDHB; SSTR; Somatostatin analog

Year:  2020        PMID： 32206131      PMCID： PMC7062954          DOI： 10.1007/s13139-019-00629-3

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  24 in total

1.  Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Ingo Janssen; Elise M Blanchet; Karen Adams; Clara C Chen; Corina M Millo; Peter Herscovitch; David Taieb; Electron Kebebew; Hendrik Lehnert; Antonio T Fojo; Karel Pacak
Journal:  Clin Cancer Res       Date:  2015-04-14       Impact factor: 12.531

2.  Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.

Authors:  Hilary C McCrary; Eric Babajanian; Matias Calquin; Patrick Carpenter; Geoffrey Casazza; Anne Naumer; Samantha Greenberg; Wendy Kohlmann; Richard Cannon; Marcus M Monroe; Jason P Hunt; Luke Buchmann
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

3.  Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.

Authors:  J C Reubi; B Waser; J C Schaer; J A Laissue
Journal:  Eur J Nucl Med       Date:  2001-07

4.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

5.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

6.  Effects of octreotide therapy in progressive head and neck paragangliomas: case series.

Authors:  Leonie T van Hulsteijn; Nicolette van Duinen; Berit M Verbist; Jeroen C Jansen; Agatha A van der Klaauw; Jan W A Smit; Eleonora P M Corssmit
Journal:  Head Neck       Date:  2013-07-30       Impact factor: 3.147

7.  Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Authors:  Martyn E Caplin; Marianne Pavel; Jarosław B Ćwikła; Alexandria T Phan; Markus Raderer; Eva Sedláčková; Guillaume Cadiot; Edward M Wolin; Jaume Capdevila; Lucy Wall; Guido Rindi; Alison Langley; Séverine Martinez; Joëlle Blumberg; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2014-07-17       Impact factor: 91.245

Review 8.  The management of head-and-neck paragangliomas.

Authors:  Cristina Capatina; Georgia Ntali; Niki Karavitaki; Ashley B Grossman
Journal:  Endocr Relat Cancer       Date:  2013-08-23       Impact factor: 5.678

9.  68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.

Authors:  Ingo Janssen; Clara C Chen; David Taieb; Nicholas J Patronas; Corina M Millo; Karen T Adams; Joan Nambuba; Peter Herscovitch; Samira M Sadowski; Antonio T Fojo; Inga Buchmann; Electron Kebebew; Karel Pacak
Journal:  J Nucl Med       Date:  2015-11-12       Impact factor: 10.057

10.  Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Abhishek Jha; Kristine de Luna; Charlene Ann Balili; Corina Millo; Cecilia Angela Paraiso; Alexander Ling; Melissa K Gonzales; Bruna Viana; Rami Alrezk; Karen T Adams; Isabel Tena; Alice Chen; Jiri Neuzil; Margarita Raygada; Electron Kebebew; David Taieb; M Sue O'Dorisio; Thomas O'Dorisio; Ali Cahid Civelek; Constantine A Stratakis; Leilani Mercado-Asis; Karel Pacak
Journal:  Front Oncol       Date:  2019-02-22       Impact factor: 6.244
View more
  4 in total

Review 1.  Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.

Authors:  Mayank Patel; Isabel Tena; Abhishek Jha; David Taieb; Karel Pacak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

2.  Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features.

Authors:  Stefan Stojanoski; Henning Bünsow Boldt; Dusko Kozic; Attila Patócs; Márta Korbonits; Milica Medic-Stojanoska; Olivera Casar-Borota
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

Review 3.  Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.

Authors:  Mickey J M Kuo; Matthew A Nazari; Abhishek Jha; Karel Pacak
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

Review 4.  Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Maran Ilanchezhian; Abhishek Jha; Karel Pacak; Jaydira Del Rivero
Journal:  Curr Treat Options Oncol       Date:  2020-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.